NCT03347968View on ClinicalTrials.gov

Study to Compare Pharmacokinetics & Pharmacodynamics of Warfarin & Esmolol in the Absence & Presence of MEDI0382

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

November 27, 2017

Primary Completion Date

April 9, 2018

Study Completion Date

April 9, 2018

Conditions
Healthy Volunteers
Interventions
BIOLOGICAL

MEDI0382

All participants will receive MEDI0382

DRUG

Warfarin

All participants will receive Warfarin

DRUG

Esmolol

All participants will receive Esmolol

Trial Locations (1)

32117

Research Site, Daytona Beach

Sponsors

Lead Sponsor

MedImmune LLC
All Listed Sponsors
lead

MedImmune LLC

INDUSTRY

NCT03347968 - Study to Compare Pharmacokinetics & Pharmacodynamics of Warfarin & Esmolol in the Absence & Presence of MEDI0382 | Biotech Hunter | Biotech Hunter